Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2.
Schiffman, Mark; Yu, Kai; Zuna, Rosemary; Terence Dunn, S; Zhang, Han; Walker, Joan; Gold, Michael; Hyun, Noorie; Rydzak, Greg; Katki, Hormuzd A; Wentzensen, Nicolas.
Int J Cancer
; 140(3): 718-725, 2017 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-27696414
Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance.
Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
Assessing the time dependence of prognostic values of cytology and human papillomavirus testing in cervical cancer screening.
Clinical significance of genotyping for human papillomavirus (HPV) 16 18/45 combined with cytology in cervical exfoliated cells in HPV oncogenic mRNA-positive women.
No Vacillation on HPV Vaccination.
Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.
DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
Reduction of cervical cancer incidence within a primary HPV screening pilot project (WOLPHSCREEN) in Wolfsburg, Germany.
The impact of HPV cervical screening on negative large loop excision of the transformation zone (LLETZ): A comparative cohort study.
Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies.